GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference

SOUTH SAN FRANCISCO, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the H.C. Wainwright Global Life Sciences Conference in London on Tuesday, April 9, 2019, at 10:10 a.m. British Summer Time.

The presentation will be webcast live from GBT’s website at www.gbt.com in the Investors section. A replay of the webcast will be archived and available for replay for one month following the event.

About GBTGBT is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing two therapies for the potential treatment of sickle cell disease, including its late-stage product candidate, voxelotor, as an oral, once-daily therapy. To learn more, please visit www.gbt.com and follow the company on Twitter @GBT_news.

Contact Information: Myesha Lacy (investors)GBT650-351-4730[email protected]

Stephanie Yao (media)GBT650-741-7730[email protected]

Source: Global Blood Therapeutics, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Why Visual Asset Repurposing Is Becoming a Competitive Advantage
• Simple Expands Retail POS Nationwide With 22+ Modules at $99 Per Month
• Sergio V. Crowley Publishes Operations Research Framework for Industrial Capital Deployment